PARP inhibitor becomes new treatment option for some men with advanced prostate cancer
Results from an international clinical trial found that men with advanced prostate cancer who have mutated BRCA1/BRCA2 genes can be
Read moreResults from an international clinical trial found that men with advanced prostate cancer who have mutated BRCA1/BRCA2 genes can be
Read more